OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids

Purdue Pharma's Transformation: A New Era in Opioid Accountability Begins This Week, Purdue Pharma, the pharmaceutical giant behind OxyContin, is stepping into a new chapter as its restructuring plan takes effect. The company has been replaced by a new entity, marking a pivotal moment in the ongoing battle against the opioid crisis. This transformation is the result of a comprehensive settlement designed to address the overwhelming number of lawsuits Purdue faced due to its role in the opioid epidemic. The new organization aims to focus on public health, with profits being channeled towards combating the opioid crisis. This development signifies a broader trend of holding pharmaceutical companies accountable for their contributions to public health challenges. As Purdue Pharma transitions into this new phase, there is cautious optimism about its potential impact on reducing opioid addiction and improving community health.